By increasing 1,25-vitamin D and calcium levels, SIK inhibition would likely restore normal FGF23 secretion and, thus, correct hyperphosphatemia, as seen in patients with hypoparathyroidism who are treated with calcitriol or calcium (8, 9). The gene discussed is FGF23; the disease is hypoparathyroidism.